GE HealthCare nabs 2 notable clearances from FDA
GE HealthCare has just nabbed two notable radiology-related clearances from the U.S. Food and Drug Administration.
On Jan. 29, the health technology giant announced the clearance of its MIM LesionID Pro—a solution from its Medical Image Merge software portfolio that simplifies the process of converting PET/CT data from whole-body PSMA scans into detailed tumor burden analyses. GE believes the tool will help reduce the burden these analyses put on providers and enhance their ability to personalize patients’ oncology treatments.
The artificial intelligence-enabled solution also assists with quantifying longitudinal changes in tumor burden over time, which is typically a time-consuming and cumbersome process that is completed manually.
"The FDA clearance of MIM LesionID Pro is a powerful step forward in our commitment to deliver intelligent, connected solutions that help clinicians make fast, confident decisions,” Jean-Luc Procaccini, president and CEO of molecular imaging and computed tomography, said in an announcement. “It’s a clear example of how we’re advancing precision care—connecting insights across platforms to support smarter care delivery and enable better patient outcomes," he added later.
On Monday, GEHC also announced an additional clearance for its Allia Moveo interventional imaging system. The compact, cable-free product comes equipped with an intuitive interface and AI-powered guidance designed to improve workflows while enabling precision imaging during procedures.
The first system was just installed at the Hôpital Marie-Lannelongue in France. Providers at the hospital have been impressed with the system’s expanded capabilities thus far, citing its simple installation and improved image quality as positive additions to their practice.
The system comes equipped with several notable features, including AI-powered image reconstruction, motion freeze tools that improve image quality during respirations, artifact reduction techniques and automated guidance that assists providers with more complex procedures in real-time.
To learn more about the new IR system, click here.
For more information on the company’s LesionID Pro tool, click here.
In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.